Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › ‘Don’t get suckered like I did’: I paid $185 to the...
Business & Finance

‘Don’t get suckered like I did’: I paid $185 to the wrong passport website. Can I get my money back?

‘Don’t get suckered like I did’: I paid $185 to the wrong passport website. Can I get my money back?
MarketWatch Thursday 30 July 2026, 11:16 UTC By Quentin Fottrell 1 min read
Key Points

“I will file a complaint with the Better Business Bureau.”

“I will file a complaint with the Better Business Bureau.”
the Better Business Bureau (ORG)
Originally published by MarketWatch Read original →

Related Stories

Passan's ultimate MLB trade deadline preview: Where all 30 teams stand, best fits and latest intel

One of the biggest deadline trades this century is days away from happening. The Tarik Skubal sweepstakes has arrived -- not officially from the Detroit Tigers, but telegraphed through the preparations of the interested teams with means to get him by the 6 p.m. ET deadline on Aug. 3. In what's expected to be Skubal's final outing with the team that drafted him and helped him develop into the reigning two-time American League Cy Young winner, the Tigers blew a 7-0 lead Wednesday and lost to...

ESPN just now

Ferrari raises 2026 guidance after Q2 earnings beat

Ferrari is bumping up its 2026 guidance after beating Wall Street's second-quarter expectations amid healthy demand for the famed Italian sports car brand's products. Here's how the company performed in the second quarter compared with average estimates compiled by LSEG: - Earnings per share: 2.62 euros ($2.97) adjusted vs. 2.50 euros expected - Revenue: 1.94 billion euros vs. 1.88 billion euros expected The automaker's new 2026 guidance includes revenue of roughly 7.6 billion euros, up from...

CNBC 10m ago

Jenrick urges Burnham to rule out tax rises to fund social care

The prime minister has not ruled out tax rises to fund a long-awaited shake-up of social care.

BBC Politics 13m ago

A16z-Backed Biotech Braveheart Seeks $318.8 Million in US IPO

A16z-Backed Biotech Braveheart Seeks $318.8 Million in US IPO Braveheart Bio Inc., a clinical-stage biopharmaceutical company backed by a16z, is seeking to raise as much as $318.8 million in an initial public offering, adding to a growing pipeline of listings in the sector. The San Francisco-based developer of drugs for cardiovascular diseases is offering 18.8 million shares for $15 to $17 each, according to a filing Thursday with the US Securities and Exchange Commission.

Bloomberg Markets 16m ago